focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,352.00
Bid: 1,346.00
Ask: 1,348.00
Change: -33.00 (-2.38%)
Spread: 2.00 (0.149%)
Open: 1,372.00
High: 1,401.00
Low: 1,339.00
Prev. Close: 1,385.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indivior to Host Capital Markets Day December 7

9 Nov 2022 08:30

RNS Number : 7168F
Indivior PLC
09 November 2022
 

 

 

Indivior to Host Capital Markets Day December 7, 2022 in New York City

Slough, UK, and Richmond, VA, November 9, 2022 - Indivior PLC (LON: INDV) today announced that it will be hosting a Capital Markets Day on Wednesday, December 7, 2022, in New York City. The event will be hosted by Mark Crossley, Chief Executive Officer, along with members of the Indivior executive leadership team. The focus of the event will be detailing the company's strategic growth plans and roadmap for delivering long-term shareholder value.

 

The event will begin at 8:30 am EST and conclude at 12:30 pm EST. Due to seating capacity, in-person participation is limited to institutional investors and analysts.

 

For those wishing to attend in person, please RSVP to investorrelations@indivior.com and further location details will be provided. Remote participants will have the ability to ask questions.

 

Further details about the Capital Markets Day can be found at cmd.indivior.com.

 

To access the live webcast, please click INDV CMD 2022.

 

A webcast replay will be available after the event has concluded.

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs approximately 1,000 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADFPESPAFFA
Date   Source Headline
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20234:52 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSTransaction in Own Shares
21st Feb 202312:15 pmRNSIndivior to Participate in Conference
21st Feb 20239:09 amRNSHolding(s) in Company
21st Feb 20237:00 amRNSTransaction in Own Shares
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20233:00 pmRNSSID & Chair of Remuneration Committee
16th Feb 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20237:00 amRNSTransaction in Own Shares
10th Feb 20234:16 pmRNSHolding(s) in Company
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20231:00 pmRNSHSR Period for Opiant Acquisition Expires
6th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20239:14 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20233:22 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20233:56 pmRNSHolding(s) in Company
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20234:37 pmRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20239:31 amRNSHolding(s) in Company
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 202311:22 amRNSHolding(s) in Company
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20233:28 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20234:26 pmRNSHolding(s) in Company
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20232:43 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20232:30 pmRNSNotice of Results
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20231:59 pmRNSHolding(s) in Company
10th Jan 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.